METHOD FOR ASSESSING THE EFFECTIVENESS OF CHEMOPREVENTIVE ACTIVITY OF RESVERATROL IN EXPERIMENTAL CARCINOGENESIS OF LIVER CANCER Russian patent published in 2020 - IPC G09B23/28 A61K31/05 A61P35/00 

Abstract RU 2736238 C1

FIELD: medicine.

SUBSTANCE: invention refers to medicine, more specifically to experimental oncology, pharmacology, namely to a method for assessing the effectiveness of chemoprophylactic activity of resveratrol in experimental carcinogenesis of liver cancer in animals. Method involves administering a substance, personalizing a mathematical model, calculating a probability of developing liver cancer. Resveratrol in dose of 100 mg/kg of body weight is administered into animals together with fodder for 6 months, and biochemical blood values are determined by N-nitrosodiethylamine in dose of 100 mg/l of water for 4 months and 6 months after the beginning of the experiment (MDA, SOD, ALT, AST, Osmotic resistance of erythrocyte membranes, GP, CAT, AP, K+-Na+-ATPases), obtained data are added to the formula: CDLC=-123.353+(1.58×A)-(0.15×B)-(0.55×C)-(3.11×D)-(4.32×E)-(0.88×F)+(13.66×G)+(0.97×H)-(3.96×I)-(54.85×J), where: CDLC – probability of developing liver cancer (%), A – Osmotic resistance of erythrocyte membranes (in% haemolysis), B – MDA (in Mmol/l), C – SOD (in %), D – ALT (in IU/l), E – AST (in IU/l), F – GP (in mcmol/l), G – CAT (in IU/gHb), H – AP (in nmol/s*l), I – K+-Na+-ATPases (in mcmol pH/ml protein/p), J is introduction of resveratrol: 1 – if administered, 0 – if not administered. Obtained result is used to assess the development of liver cancer with subsequent evaluation of the effectiveness of chemoprophylactic activity of resveratrol: 0 to 30 % – high chemoprophylactic activity; from 30 % to 60 % – average chemoprophylactic activity; 60–100 % low chemoprophylactic activity.

EFFECT: disclosed method enables assessing the effectiveness of chemoprophylactic activity of resveratrol in experimental carcinogenesis of liver cancer and calculating an individual clinical prediction, having high accuracy.

1 cl, 1 tbl, 6 ex

Similar patents RU2736238C1

Title Year Author Number
METHOD FOR PREDICTION OF LIVER CANCER RISK IN EXPERIMENTAL ANIMALS 2018
  • Kokoev Leonid Aleksandrovich
  • Tomaeva Kristina Guramovna
  • Bolieva Laura Zelimkhanovna
RU2699932C1
METHOD OF ASSESSING THE SEVERITY OF LIVER DYSFUNCTION IN CATTLE 2022
  • Kuzminova Elena Vasilevna
  • Abramov Andrej Andreevich
  • Miroshnichenko Petr Vasilevich
  • Koshchaev Andrej Georgievich
  • Semenenko Marina Petrovna
  • Osepchuk Denis Vasilevich
  • Rodin Matvej Igorevich
  • Dolgov Evgenij Petrovich
RU2803003C1
METHOD FOR ASSESSING THE FUNCTIONAL STATE OF THE LIVER OF CATTLE 2021
  • Abramov Andrej Andreevich
  • Kuzminov Nikita Dmitrievich
  • Grin Vladimir Anatolevich
  • Kuzminova Elena Vasilevna
  • Semenenko Marina Petrovna
  • Chernykh Oleg Yurevich
  • Rogaleva Evgeniya Viktorovna
  • Rud Ekaterina Nikolaevna
RU2773414C1
CORRECTIVE COMPOSITION FOR PATHOLOGIC CARBOHYDRATE, LIPID DISBOLISM AND ANTIOXIDANT ORGANISM STATE INVOLVEMENT 2008
  • Artjukov Aleksandr Alekseevich
  • Kozlovskaja Ehmma Pavlovna
  • Popov Aleksandr Mikhajlovich
  • Glazunov Valerij Petrovich
  • Kozlovskij Aleksej Stefanovich
  • Kupera Elena Vladimirovna
  • Rutskova Tat'Jana Anatol'Evna
  • Kurika Aleksandr Vasil'Evich
  • Balaganskij Aleksandr Petrovich
RU2360683C1
METHOD OF INCREASING ERYTHROCYTE MEMBRANE STABILITY IN CONDITIONS OF EXPERIMENTAL CARCINOGENESIS 2015
  • Kokoev Leonid Aleksandrovich
  • Bolieva Laura Zelimkhanovna
  • Kaboeva Bella Nikolaevna
RU2588317C1
THERAPEUTIC AGENT FOR PREVENTING AND TREATING CHRONIC LIVER DISEASES 2012
  • Nikolaevskij Vladimir Anatol'Evich
  • Zoloedov Vladimir Ivanovich
  • Lobeeva Nelja Vasil'Evna
  • Miroshnichenko Lidija Aleksandrovna
  • Muzalevskaja Ekaterina Nikolaevna
RU2526172C2
METHOD FOR TREATING PATIENTS SUFFERING FROM ACUTE VIRAL HEPATITIS B AGGRAVATED WITH CHOLESTATIC SYNDROME 2000
  • Makarenko M.V.
  • Makarenko A.M.
  • Sytin M.L.
  • Gotlib D.K.
RU2173179C1
METHOD OF TREATING MODERATELY ACTIVE AND REPLICATIVE CHRONIC VIRAL HEPATITIS TYPE C OF 1-GENOTYPE 2009
  • Sologub Tamara Vasil'Evna
  • Semenjako Nadezhda Aleksandrovna
  • Kremen' Nadezhda Vasil'Evna
RU2398582C1
METHOD OF DETERMINING EFFECTIVENESS OF TREATMENT OF ENDOTHELIAL DYSFUNCTION IN METABOLIC AND FUNCTIONAL DISORDERS IN EXPERIMENTAL RATS 2023
  • Dzugkoev Sergej Gavrilovich
  • Dzugkoeva Fira Solomonovna
  • Margieva Olga Ivanovna
  • Khubulova Anna Elizbarovna
  • Mozhaeva Irina Viktorovna
RU2808420C1
METHOD FOR SELECTION OF MEDICINAL PREPARATIONS FOR TREATMENT OF PATIENTS WITH CHRONIC VIRAL HEPATITIS C 2002
  • Baskovich G.A.
  • Stel'Makh V.V.
  • Shabrov A.V.
  • Radchenko V.G.
RU2221243C1

RU 2 736 238 C1

Authors

Kokoev Leonid Aleksandrovich

Rakitskij Valerij Nikolaevich

Bolieva Laura Zelimkhanovna

Tomaeva Kristina Guramovna

Dates

2020-11-12Published

2020-05-12Filed